Evidence map›Paper›PMID 39495651›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

Living Therapeutics for Synergistic Hydrogen-Photothermal Cancer Treatment by Photosynthetic Bacteria.

Yingyi Zhang, Xiaolian Deng, Lili Xia, Jianghui Liang, Meng Chen, Xiaoling Xu, Wei Chen, Jianwei Ding, Chengjie Yu, Limei Liu and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Yingyi ZhangDepartment of Pharmacology, School of Medicine, Shenzhen Campus of Sun Yat-Sen University, Shenzhen, 518107, P. R. China.
Xiaolian DengDepartment of Pharmacology, School of Medicine, Shenzhen Campus of Sun Yat-Sen University, Shenzhen, 518107, P. R. China.
Lili XiaMaterdicine Lab, School of Life Sciences, Shanghai University, Shanghai, 200444, P. R. China.
Jianghui LiangDepartment of Pharmacology, School of Medicine, Shenzhen Campus of Sun Yat-Sen University, Shenzhen, 518107, P. R. China.
Meng ChenKey Laboratory of Quantitative Synthetic Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academic of Science, Shenzhen, 518000, P. R. China.
Xiaoling XuDepartment of General Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Zhejiang, 310016, P. R. China.
Wei ChenDepartment of General Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Zhejiang, 310016, P. R. China.
Jianwei DingDepartment of Chemical and Biomolecular Engineering, National University of Singapore, Singapore, 117585, Singapore.
Chengjie YuDepartment of Pharmacology, School of Medicine, Shenzhen Campus of Sun Yat-Sen University, Shenzhen, 518107, P. R. China.
Limei LiuDepartment of Pharmacology, School of Medicine, Shenzhen Campus of Sun Yat-Sen University, Shenzhen, 518107, P. R. China.
Yang XiangDepartment of Pharmacology, School of Medicine, Shenzhen Campus of Sun Yat-Sen University, Shenzhen, 518107, P. R. China.
Yiliang LinDepartment of Chemical and Biomolecular Engineering, National University of Singapore, Singapore, 117585, Singapore.
Fangfang DuanDepartment of Pharmacology, School of Medicine, Shenzhen Campus of Sun Yat-Sen University, Shenzhen, 518107, P. R. China.
Wei FengMaterdicine Lab, School of Life Sciences, Shanghai University, Shanghai, 200444, P. R. China.
Yu ChenMaterdicine Lab, School of Life Sciences, Shanghai University, Shanghai, 200444, P. R. China.ORCID 0000-0002-8206-3325
Xiang GaoKey Laboratory of Quantitative Synthetic Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academic of Science, Shenzhen, 518000, P. R. China.

Funding

Guangdong Basic and Applied Basic Research Foundation 2024A1515010500Guangdong Basic and Applied Basic Research Foundation 2024B1515020102National Key R&D Program of China 2021YFA0909900National Natural Science Foundation of China 32000543National Natural Science Foundation of China 52072393National Natural Science Foundation of China 52272279National Natural Science Foundation of China 82272104Shanghai Science and Technology Committee Biomedical Program 23S11900900Shenzhen Science and Technology Program ZDSYS20220606100606013
6 · The paper itself

Abstract

Hydrogen gas (H

Indexed as

HydrogenPhotothermal TherapyRhodobacter sphaeroidesAnimalsCell Line, TumorDisease Models, AnimalHumansMiceNeoplasmsPhotosynthesisHydrogenhydrogen‐photothermal therapyhydrogen therapyliving bacterial therapiesphotosynthetic bacteria

Identifiers

PMID39495651
PMCPMC11714200

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.